Consortium International Holdings, LLC (CIH) is a USA based entity with over 20 years of combined experience in infectious diseases. Through the experience and relationships developed and maintained internationally, CIH has entered into the fight against Covid-19 providing high quality SARS Co-V2 (Covid-19) testing technologies with highly sensitive and specific IgG/IgM Antibody Rapid test as well as our Antigen Rapid test. CIH also has available  a highly competitive Real-Time PCR for the detection of 2019 SARS CoV-2 Kit and the newly announces SARS-CoV-2 & Influenza A/B Nucleic Acid Detection Kit.

Through our continuing Research and Development program we are proud to introduce into the international markets, a highly sensitive and specific Antigen Rapid Test and our SARS-CoV-2 & Influenza A/B Nucleic Acid Detection Kit which is now available to those markets outside of the USA.


We invite you to please view our product lists and determine those testing products that will best meet your requirements. Our goal is to work with you and your staff to deliver quality products, proven to perform and that deliver reliable and repeatable results.


We are proud that our Covid-19 Antibody Rapid test have received the US FDA Emergency Use Authorized and available throughout the USA as well as internationally along with our Real-Time PCR for the detection of 2019 SARS CoV-2.


Currently, 0ur Antigen Rapid test is available internationally as is our SARS-CoV-2 &Influenza A/B Nucleic Acid Detection. Pending the EUA issuance, our Antigen Rapid test and our SARS-CoV-2 &Influenza A/B Nucleic Acid Detection will  be made available for shipment and use within the USA. All tests are European CE Mark compliant and available for shipment to the appropriate markets.  All products are available for professional use only.


For more information contact:

Consortium International Holdings  

Miami Beach, Florida, 33139 USA 

Phone: +1.305.978.4590

Fax: +1.305.437.8120

Email:  info@consortiummiami.com